Xifaxan 550 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FQ2CW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,278
Award facts
- Contract value 100% obligated
- $13,277.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $13,277.62 delivery order to Amerisourcebergen Drug Corp on May 28, 2026, for Xifaxan 550 mg tablets (60-count packaging). The order ceiling is $13,277.62 and is firm fixed price with an ultimate completion date of May 29, 2026.
Place of performance is Conshohocken, PA. The delivery order was issued without a set-aside under a DLA parent indefinite delivery contract supporting pharmaceutical distribution to Defense Health Agency and military medical facilities.
Quick answers
Who was awarded contract SPE2DR26FQ2CW?
SPE2DR26FQ2CW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 28, 2026.
How much is contract SPE2DR26FQ2CW worth?
The government has obligated $13,278 on SPE2DR26FQ2CW.
Is contract SPE2DR26FQ2CW an order under another contract?
Yes. SPE2DR26FQ2CW is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FQ2CW competed?
The extent of competition for SPE2DR26FQ2CW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award